RCKT — Rocket Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $251.38m
- -$11.09m
Rocket Pharmaceuticals Inc expected to post a loss of 79 cents a share - Earnings Preview
Brief: Rocket Pharmaceuticals Announces Update On FDA Review Timeline Of KRESLADI
Brief: Rocket Pharmaceuticals Appoints R. Keith Woods To Board Of Directors
Brief: Rocket Pharmaceuticals Q3 EPS USD -0.75
Rocket Pharmaceuticals Inc expected to post a loss of 81 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Apple, MGM Resorts International, Madrigal
U.S. STOCKS ON THE MOVE-Akili, Navios Maritime Holdings, Madrigal
U.S. STOCKS ON THE MOVE-Rocket Lab, Rocket Pharma, Moderna
Rocket Pharma rises on FDA alignment on trial design for rare disorder therapy
Brief: Rocket Pharmaceuticals Announces Pricing Of Public Offering Of Common Stock
Brief: Rocket Pharmaceuticals Announces Proposed Public Offering Of Common Stock
Brief: Rocket Pharmaceuticals Reaches FDA Alignment On Pivotal Phase 2 Trial Design For Rp-A501 In Danon Disease
Rocket Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary
Rocket Pharmaceuticals Inc expected to post a loss of 79 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Constellation Energy, Cactus, Cardinal Health
U.S. STOCKS ON THE MOVE-CureVac, Aclarion, Baosheng Media
Brief: Rocket Pharmaceuticals Receives FDA Fast Track For RP-A601 Gene Therapy
Rocket Pharma rises on FDA's 'fast track', 'orphan drug' tags for gene therapy
Brief: Rocket Pharma Receives European Medicines Agency Priority Medicines Designation For Gene Therapy For Danon Disease